Scholarlink

Purpose of Review <p> Evaluating lung transplant candidates with underlying systemic autoimmune rheumatic diseases is challenging due to a wide spectrum of extrapulmonary manifestations, leading to variable practice among centers. This article aims to define autoimmune disease activity and treatment failure, discuss post-transplant complications of pre-transplant immunosuppression, propose criteria for timely lung transplant referral, and discuss management of rheumatologic manifestations after lung transplant.</p> Recent Findings <p> The guidelines and rheumatological considerations in lung transplant candidates remain unclear, with poorly understood effects of autoimmune disease on lung transplant outcomes and acceptance criteria for these risks.</p> Summary <p> In this review, we will discuss the important gray areas in the rheumatological considerations for lung transplant candidates, specifically addressing diagnostic uncertainty and therapeutic dilemmas involved, as well as the need for standardization protocols among lung transplant centers on rheumatological evaluation and considerations. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Rheumatologic Considerations in Lung Transplant Candidates

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月25日

查看全文
  • Maria M. Crespo,
  • Amparo Sole,
  • Nora Sandorfi,
  • Andrew Gross,
  • Adriana Valverde Zúñiga,
  • Aida Venado

摘要

Purpose of Review

Evaluating lung transplant candidates with underlying systemic autoimmune rheumatic diseases is challenging due to a wide spectrum of extrapulmonary manifestations, leading to variable practice among centers. This article aims to define autoimmune disease activity and treatment failure, discuss post-transplant complications of pre-transplant immunosuppression, propose criteria for timely lung transplant referral, and discuss management of rheumatologic manifestations after lung transplant.

Recent Findings

The guidelines and rheumatological considerations in lung transplant candidates remain unclear, with poorly understood effects of autoimmune disease on lung transplant outcomes and acceptance criteria for these risks.

Summary

In this review, we will discuss the important gray areas in the rheumatological considerations for lung transplant candidates, specifically addressing diagnostic uncertainty and therapeutic dilemmas involved, as well as the need for standardization protocols among lung transplant centers on rheumatological evaluation and considerations.